Zeba Syed

Dr. Zeba Syed


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 February 2021 in Current Opinion in Ophthalmology
Verified
Journal Article
Closed access
ZSZeba Syed
Zeba Syed
CRChristopher J. Rapuano
Christopher J. Rapuano
Purpose of review: Rho kinase (ROCK) inhibitors are growing increasingly relevant in ophthalmology, and the goal of this review is to summarize their mechanisms of action and potential applications in the subspecialties of glaucoma, retina, and cornea. We will focus specifically on corneal endothelial wound healing, for which ROCK inhibition demonstrates particular promise. Recent findings: ROCK inhibition has been shown to promote corneal endothelial cell proliferation, increase intercellular adhesion, and suppress apoptosis. Topical ROCK inhibitor treatment has exhibited potential use in Fuchs endothelial dystrophy, corneal edema from acute surgical trauma and other etiologies, and tissue engineering therapy for the endothelial disease. Ripasudil and netarsudil, the two ROCK inhibitors available for ophthalmic use, are generally very well tolerated with mild and transient local side effects. Summary: ROCK inhibitors are revolutionizing the subspecialty of cornea, and further research is needed to compare long-term outcomes of ROCK inhibitor therapy to those of conventional endothelial keratoplasty, including visual acuity and endothelial cell density. Other possible avenues include the use of ROCK inhibitors to prolong corneal graft survival, and early data appears promising.

1 September 2019 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
DBDurga S. Borkar
Durga S. Borkar
TWTurner D. Wibbelsman
Turner D. Wibbelsman
PBPreema M. Buch
Preema M. Buch
SRSara B. Rapuano
Sara B. Rapuano
AOAnthony Obeid
Anthony Obeid
ZSZeba Syed
Zeba Syed

19 March 2020 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
NDNicolas Dohse
Nicolas Dohse
TWTurner D. Wibbelsman
Turner D. Wibbelsman
SRSara B. Rapuano
Sara B. Rapuano
KHKristin M. Hammersmith
Kristin M. Hammersmith
PNParveen K. Nagra
Parveen K. Nagra
ZSZeba Syed
Zeba Syed

1 June 2023 in Turkish Journal of Ophthalmology
Verified
Journal Article
Open access
MCMarcos A. Crespo
Marcos A. Crespo
CRChristopher J. Rapuano
Christopher J. Rapuano
ZSZeba Syed
Zeba Syed
Kornea ve Oküler Yüzey Hastalıklarında Mitomisin C Kullanımı

1 July 2021 in Eye & Contact Lens: Science & Clinical Practice
Verified
Journal Article
Closed access
JYJulia B.S. Yu
Julia B.S. Yu
ZSZeba Syed
Zeba Syed
CRChristopher J. Rapuano
Christopher J. Rapuano
Infectious scleritis (IS) is a rare and severe ocular disorder responsible for approximately 5%–15% of all scleritis cases. It is often associated with a poor prognosis due to its similar clinical presentation to autoimmune scleritis, resulting in a delayed diagnosis and treatment. Therefore, differentiating between infectious and noninfectious entities is critical. Several details extracted from the patient's history and clinical examination can raise suspicion for infection. The most common predisposing factor is previous ocular surgery, especially pterygium, cataract, and vitreoretinal surgeries. Ocular trauma, poor contact lens hygiene, “eye-whitening” procedures, and subtenon triamcinolone injections have also been implicated. Clinical features of infection include the presence of scleral necrosis, hypopyon, unifocal or multifocal scleral abscesses, and mucopurulent discharge. Thorough diagnostic testing is essential before excluding infection as a possibility. Empiric broad-spectrum topical and systemic antibiotic therapy should be initiated while awaiting laboratory results and adjusted accordingly. Most IS cases require both aggressive medical and surgical treatment, and various studies have reported favorable outcomes with this combination. At this time, there is no consensus on the management of this severe ocular condition, and future studies are needed to establish clear treatment guidelines.

1 June 2021 in American Journal of Ophthalmology
Verified
Journal Article
Open access
ESEric J. Shiuey
Eric J. Shiuey
QZQiang Zhang
Qiang Zhang
CRChristopher J. Rapuano
Christopher J. Rapuano
BABrandon D. Ayres
Brandon D. Ayres
KHKristin M. Hammersmith
Kristin M. Hammersmith
ZSZeba Syed
Zeba Syed
To develop a nomogram to predict the 3- and 5-year likelihood of graft survival after penetrating keratoplasty (PK) based on preoperative assessment and intraoperative plan. Retrospective clinical case-control study. Data from 1,029 consecutive PKs in 903 eyes of 835 patients performed at a single tertiary center from May 2007 to September 2018 were extracted from electronic medical records and evaluated for corneal graft failure, defined as irreversible and visually significant graft edema, haze, or scarring. Thirty-seven variables were assessed by multivariable Cox models. A nomogram to predict the probability of graft survival was created. Mean recipient age was 57.1 ± 22.0 years and mean follow-up was 4.22 ± 3.05 years. Overall, 37.4% of grafts failed during follow-up. Eleven variables were significantly associated with graft failure, including active microbial infection at the time of PK (hazard ratio [HR] = 5.10, 95% confidence interval [CI] 3.53-7.37), intraocular silicone oil at the conclusion of the PK (HR = 4.28, 95% CI 2.38-7.71), history of systemic autoimmune disease (HR = 2.83, 95% CI 1.63-4.90), 4 quadrants of corneal neovascularization (HR = 2.76, 95% CI 1.56-4.86), any prior anterior segment surgery (HR = 2.41, 95% CI 1.55-3.75), and lens status as anterior chamber intraocular lens at the conclusion of surgery (HR = 2.35, 95% CI 1.30-4.26). The nomogram exhibited a concordance index of 0.76 (95% CI 0.74-0.78); internal calibration plots depicted strong correlation between prediction and observation of graft survival. PK graft prognosis may be predicted relatively accurately based on 11 variables. Although established from retrospective data, this nomogram would be valuable for data-driven patient counseling prior to corneal transplantation.